🔓 Unlock the full profile of Omri Shor (Medisafe®), including verified contact details, financial insights, and professional associations.
See Omri Shor Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: omr*****@med******.com
Mobile: 81377*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Omri Shor is the Founder and CEO of Medisafe®, a company established in 2012 and headquartered in Boston, Massachusetts, specializing in medication management solutions.
- Under Omri Shor's leadership, Medisafe® has developed a widely recognized app that helps patients manage their medications effectively, focusing on improving adherence and health outcomes.
- Medisafe® was founded to address the challenges of medication non-adherence, which is a significant issue in healthcare leading to poor health outcomes and increased healthcare costs.
- Before founding Medisafe®, Omri Shor co-founded Marina123 and served as its CEO, demonstrating a strong background in entrepreneurship and leadership in the technology sector.
- Prior roles include Marketing and Product Director at Masadit Software, where Omri contributed to product development and marketing strategies while being the first employee of the company.
- In earlier positions, Omri was Marketing and Sales Director at Yedioth Ahronoth, managing two sales teams, showcasing early leadership skills in sales and marketing.
- Omri has a proven track record of establishing and leading teams, as seen in various roles, including VP of Sales & Delivery at Sharim Productions and Sales Team Leader at Bezeq On Line.
- Medisafe® has made significant strides in expanding its user base, with a current Alexa ranking of 558,803, indicating a growing presence in the digital health space.
- Omri Shor actively engages with the community through Medisafe®'s social media channels, including Facebook and Twitter, to promote health literacy and medication adherence.
- The organization has faced challenges, including headcount fluctuations; however, it continues to push for growth and innovation in medication management technology.